Pharma: Clinic Roundup
Monday, November 12, 2012
Chiromics LLC, of Princeton, N.J., is collaborating with London-based GlaxoSmithKline plc to discover new classes of small molecules against certain biological targets. Chiromics' compound collections are assembled using its core chemical technology referred to as cascade catalysis.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.